$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Dec 3, 2025)
$537.63M
Market Cap
-
P/E Ratio
-4.62
EPS
$39.71
52 Week High
$7.75
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Assembly Biosciences, Inc. (ASMB) is a clinical-stage biotechnology company based in South San Francisco, California, dedicated to developing innovative therapies targeting viral infections and liver diseases, principally hepatitis B. The company’s proprietary core inhibitor technology underpins a robust pipeline of drug candidates designed to meet significant unmet medical needs in chronic infection treatment. With a strategic focus on transforming current treatment paradigms, Assembly Biosciences represents a compelling investment opportunity for institutional investors looking to capitalize on breakthroughs in the biopharmaceutical industry.
LPTX
VRAX
IRBT
VHAI
NVDA
PLUG
IPG
NIO
TSLA
RR
ASST
BYND
BITF
INTC
CAPR
ADAP
IREN
VALE
AAL
MRVL
NFLX
SOFI
PFE
DNN
F
MARA
BTBT
MTSR
CLSK
CIFR
QBTS
WULF
PLTD
AEO
RIG
KVUE
GOOGL
AVGO
AMD
MSFT
ASBP
PCG
PMAX
PLTR
HTOO
PYPL
CGC
BMY
BAC
HBAN
MSTR
RGTI
GTLB
M
HOOD
CRDO
ALIT
SNAP
DVLT
BE
PSTG
NOK
T
FCX
GOOG
LPTX
VRAX
IRBT
VHAI
NVDA
PLUG
IPG
NIO
TSLA
RR
ASST
BYND
BITF
INTC
CAPR
ADAP
IREN
VALE
AAL
MRVL
NFLX
SOFI
PFE
DNN
F
MARA
BTBT
MTSR
CLSK
CIFR
QBTS
WULF
PLTD
AEO
RIG
KVUE
GOOGL
AVGO
AMD
MSFT
ASBP
PCG
PMAX
PLTR
HTOO
PYPL
CGC
BMY
BAC
HBAN
MSTR
RGTI
GTLB
M
HOOD
CRDO
ALIT
SNAP
DVLT
BE
PSTG
NOK
T
FCX
GOOG